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Problem Identification
◦ Cancer is the leading cause of death in Vermont and the second leading cause of death in the U.S. 1 More
than 1000 Vermonters die from cancer each year (Figure 1).2
◦ Cancer screening can lead to early detection, prolonging patients’
longevity and reducing deaths. Most primary care providers (PCP)
use cancer screening guidelines developed by United States
Preventive Services Task Force (USPST), but large disparities exist
between the guidelines and the actual delivery and compliance of
cancer screening.3 In a recent survey study which included
Vermont providers, 76% of PCP participants reported screening
practices that were not in accordant with USPST recommendations
for breast cancer.4

◦ A more effective risk-based screening system is needed to
address this problem.

Figure 1. Age adjusted cancer mortality rates
per 100,000 population, 2010-2014.2
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Public Health Cost
◦ Cancer screening tests are expensive. The annual Medicare cost for breast cancer screening was $1.08 billion
in the U.S.5 In order to reduce cost and resources, screening guidelines are progressing from age-based
approach to more personalized risk-based approach.
◦ Detecting cancer at earlier stage can reduce treatment costs. In a study of 8360 women diagnosed with breast
cancer, the treatment costs were higher for those who were diagnosed at a more advanced stage (Figure 2).6
Breast Cancer Stage at
Diagnosis

Treatment Cost per Patient in 24
months after diagnosis

Stage 0

$71,909

Stage I/II

$97,066

Stage III

$159,442

Stage IV

$182,655

Figure 2. Breast cancer treatment costs based on stage at diagnosis.6
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Community Perspective
◦ “Primary care providers have limited time with each patient. During preventative visits,
patients often bring up multiple acute issues that need to be addressed immediately. It is
difficult for providers to conduct screening according to the constantly changing
guidelines.”
Family Medicine Physician at Milton, VT

◦ “I was so anxious about my risk for cancer due to my complex family history of cancer.
My wonderful primary doctor referred me to the genetic counseling specialists in order to
find out which screening I should go through. That process took so long!”
30 y.o. Patient
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Intervention and Methodology
◦ The Vermont Cancer Risk Questionnaire was developed by Dr. John King
and Brian Sprague PhD. based on the risk factors of common cancers. The
questionnaire contains 20 questions which assessed risk factors for lung,
colon, breast, prostate, and cervical cancer and reviewed cancer family
history. The draft needed input from patients and clinicians.

◦ Seven patients and three family medicine attendings/residents at the Milton
clinic were interviewed. Participants were asked to fill out the questionnaire
and to give specific feedback on the presentation, length, wording, and
content of the questionnaire. The chosen patient participants varied in age
and sex. Each interview took about 15-20 minutes.
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Results

Patient Demographics
Sex at birth

Female

Female

Female

Male

Male

Male

Male

Age

21

25

56

28

47

51

59

Patients (n=7)

Clinicians (n=3)

What do you like
about the
questionnaire?

• Good length
• Well-written questions
• Simple wording

What part of the
questionnaire do
you not
understand?

• #1: The columns for “If
What needs to be
Current Smoker” and “If
changed?
Former Smoker” are unclear
• #2 and #3: None of the
patients knew all the chemicals
mentioned.
• #20: The checkboxes make the
table too complex to
understand.

What do you like
about the
questionnaire?

• Good length
• Simple for patients to understand
• Ask about patient’s cancer history
• Instead of screening exposure to the
specific chemicals, screen for careers
with high-risk to exposure
• Use standardized race categories
• Utilize the cancer screening
questions from BRFSS and compare
the questionnaire results to national
data
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Evaluation of Effectiveness and Limitation
Effectiveness
◦ The questionnaire was mortified based on these feedbacks.
◦ After taking the survey, several patients expressed interests to learn about their cancer risk. A patient even
expressed interest to learn about his family members’ cancer risk.

◦ Physicians were interested to learn about the implications of this questionnaire for their practice.
Limitations
◦ The questionnaire is relevant to age 21-80, but the oldest interview participant is 59.
◦ Since responses are self-reported, it is difficult to assess the accuracy of patients’ responses.
◦ Many patients asked for risk estimates after taking the questionnaire, but we are still in the process of
developing an informational output system.
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Future Steps
◦ Use cognitive interviewing techniques to assess the accuracy of responses. Participants
will think out loud as they complete the questionnaire. The interview will be repeated
multiple times, and the responses of each round will be compared.

◦ Build the questionnaire into PRISM
◦ Implement the questionnaire at two UVMMC primary care clinics. The data will provide
longitudinal data for developing a cancer risk prediction algorism. The goal of this
algorism is to guide cancer screening decision-making for clinicians and patients.

The author would like to thank the wonderful staff at the Milton Family Practice for making this project possible.
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